Erratum to: Adv Ther DOI 10.1007/s12325-017-0522-y
The authors of this manuscript have noticed a mistake since publication of their manuscript.
In the original publication, the “Total RTX consumption per patient (mg)” in Table 1, was incorrectly published as 1814.00. The correct value of “Total RTX consumption per patient (mg)” should read as 11,814.00.
Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s12325-017-0522-y.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Gulácsi, L., Brodszky, V., Baji, P. et al. Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries. Adv Ther 34, 1234 (2017). https://doi.org/10.1007/s12325-017-0538-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-017-0538-3